Dr Lalchandani Labs IPO vs Garv Industries IPO

Comparison between Dr Lalchandani Labs IPO and Garv Industries IPO.

IPO Details

Dr Lalchandani Labs IPO is a SME Fixed Price IPO proposed to list at BSE SME while Garv Industries IPO is a SME Fixed Price proposed to list at BSE SME.

Issue Size and Price

The total issue size of Dr Lalchandani Labs IPO is up to ₹3.98 Cr whereas the issue size of the Garv Industries IPO is up to ₹3.03 Cr. The final issue price of Dr Lalchandani Labs IPO is ₹30.00 per share and of Garv Industries IPO is ₹10.00 per share.

 Dr Lalchandani Labs IPOGarv Industries IPO
Face Value₹10 per share₹10 per share
Issue Price (Final)₹30.00 per share₹10.00 per share
Discount (Retail)₹0.00 per share₹0.00 per share
Market Lot Size4000 shares10000 shares
Fresh Issue Size13,28,000 shares30,30,000 shares
Fresh Issue Size (Amount)up to ₹3.98 Crup to ₹3.03 Cr
OFS Issue Size0 shares0 shares
OFS Issue Size (Amount)up to ₹0.00 Crup to ₹0.00 Cr
Issue Size Total13,28,000 shares30,30,000 shares
Issue Size Total (Amount)up to ₹3.98 Crup to ₹3.03 Cr

IPO Timetable

Dr Lalchandani Labs IPO opens on Apr 25, 2018, while Garv Industries IPO opens on Apr 12, 2018. The closing date of Dr Lalchandani Labs IPO and Garv Industries IPO is Apr 27, 2018, and Apr 17, 2018, respectively.

Financials & KPIs

Dr Lalchandani Labs IPO P/E ratio is , as compared to Garv Industries IPO P/E ratio of .

 Dr Lalchandani Labs IPOGarv Industries IPO
Financials

Company Financials (Restated)

Period Ended31 Jan 201831 Mar 201731 Mar 201631 Mar 2015
Assets6.033.763.661.87
Total Income2.054.623.031.93
Profit After Tax0.240.710.320.32
NET Worth3.270.920.870.40
Reserves and Surplus0.37
Total Borrowing1.511.771.550.68
Amount in ₹ Crore

Company Financials (Restated)

Period Ended31 Jan 2018
Assets10.36
Total Income14.59
Profit After Tax0.11
NET Worth6.93
Reserves and Surplus0.11
Total Borrowing0.01
Amount in ₹ Crore
Promoter Shareholding (Pre-Issue)89.80%100%
Promoter Shareholding (Post-Issue)60.78%68.63%
Market Cap₹13.00 Cr.₹10.20 Cr.

Shares Offered

In the Dr Lalchandani Labs IPO Retail Individual Investors (RII) are offered 6,64,000 shares while in Garv Industries IPO retail investors are offered 6,64,000 shares. Qualified Institutional Buyers (QIB) are offered 0 shares in Dr Lalchandani Labs IPO and 0 shares in Garv Industries IPO.

 Dr Lalchandani Labs IPOGarv Industries IPO
Anchor Investor Reservation0 shares0 shares
Market Maker Reservation72,000 shares1,70,000 shares
QIB0 shares0 shares
NII6,64,000 shares15,15,000 shares
RII6,64,000 shares15,15,000 shares
Employee0 shares0 shares
Total13,28,000 shares30,30,000 shares

Bids Received (Subscription)

Dr Lalchandani Labs IPO subscribed 4.63x in total, whereas Garv Industries IPO subscribed 2.13x.

 Dr Lalchandani Labs IPOGarv Industries IPO
NII (times)3.13x2.28x
RII (times)6.13x1.98x
Total (times)4.63x2.13x

Compare with others

Compare:

Dr Lalchandani Labs IPO Vs Garv Industries IPO